期刊文献+

FDA批准盐酸维拉佐酮治疗重度抑郁症 被引量:2

原文传递
导出
摘要 美国食品药品管理局(FDA)2011年1月21日批准盐酸维拉佐酮(商品名Viibryd)片剂用于治疗成人重度抑郁症。Vi—ibryd属5-HT1A部分激动剂和选择性-HT再摄取抑制剂(selective serotonin reuptake inhibitor,SSRI)双重活性药物,也是第一个吲哚烷基胺类新型抗抑郁药。Viibryd片剂有不同的规格,分别为10、20、40mg。
作者 董江萍
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第6期462-462,共1页 Chinese Pharmaceutical Journal
  • 相关文献

同被引文献19

  • 1吴金华,王鹏.曲坦类化合物的合成研究[J].化工中间体,2006,2(3):28-30. 被引量:3
  • 2Blier P. The pharmacology of putative early-onset antidepressant strategies[J]. Eur Neuropsychopharmacol, 2003, 13(2): 57- 66.
  • 3Pearce EF, Murphy JA. Vortioxetine for the treatment of depression[J]. Ann Pharmacother, 2014, 48(6): 758-765.
  • 4Mago R, Mahajan R, Thase ME. Levomilnacipran: a newly approved drug for treatment of major depressive disorder[J]. Expert Rev Clin Pharmacol, 2014, 7(2): 137-145.
  • 5Chen L, Boinpally R, Greenberg WM, et al. Effect of hepatic impairment on the pharmacokinetics of levomilnacipran following a single oral dose of a levomilnacipran extended- release capsule in human participants[J]. Clin Drug Investig, 2014, 34(5): 351-359.
  • 6医脉通.FDA批准新型SNRI类药物治疗抑郁[EB/OL].(2013-07-29) [2014-08-13 ]. http://news.medlive, cn/psy/info- progress/show-50871 60.html.
  • 7Laughren TP, Gobburu J, Temple RJ, et al. Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressant[J]. J Clin Psychiatry, 201 l, 72(9): 1166-1173.
  • 8Dawson LA. The discovery and development of vilazodone for the treatment of depression: a novel antidepressant or simply another SSRI? [J]. Expert Opin Drug Discov, 2013, 8(12): 1529-1539.
  • 9Polu6ktov MG, Levin YI. The results of the Russian multicenter open observational non-comparative study on the efficacy and safety of valdoxan (agomelatin) in the treatment of patients with major depressive disorder and insomnia (the VIVALDI study)[J]. Zh Nevrol Psikhiatr Im S S Korsakova. 2013, 113(12): 39-44.
  • 10Chaskar A.Highly efficient and facile green approach for onepot fischer indole synthesis[J].Journal of the Korean Chemical Society,2010,54(4):411-413.

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部